2024医药行业政策通行证_理解医药创新以提高新疗法的可及性研究报告(英)-中国食药促进会.docx

下载文档

0
0
约11.44万字
约 121页
2024-11-01 发布于山西
举报
版权申诉
保障服务

2024医药行业政策通行证_理解医药创新以提高新疗法的可及性研究报告(英)-中国食药促进会.docx

此“医疗卫生”领域文档为创作者个人分享资料，不作为权威性指导和指引，仅供参考

1、本文档共121页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

Pharmaceutical

POLICYPASSPORT

Understandingpharmaceuticalinnovationtoimproveaccesstonewtreatments

SpecialEdition–EUPharmaceuticalLegislationReform

MSD

INVENTINGFORLIFE

MSDISALEADINGBIOPHARMACEUTICALCOMPANYTHATFOCUSESONCUTTING-EDGERESEARCHTOSAVEANDIMPROVELIVESGLOBALLY.OURMISSIONISTOHARNESSTHEPOWEROFSCIENCE

TOADVANCETHEPREVENTIONANDTREATMENTOFDISEASESINHUMANSANDANIMALS.

FORMORETHAN130YEARS,WEHAVEBROUGHTHOPETHROUGHTHEDEVELOPMENTOFIMPORTANTMEDICINESANDVACCINES.TODAY,WEAREATTHEFOREFRONTOFRESEARCH

TODELIVERINNOVATIVEHEALTHSOLUTIONSTHATADVANCETHEPREVENTIONANDTREATMENTOFDISEASESINPEOPLEANDANIMALS.

TOLEARNMOREABOUTMSD,PLEASEVISITOURWEBSITEATMSD.COM

MSD

MSDPOLICYPASSPORTAKNOWLEDGE-BASEDECONOMY3

WHYAPOLICYPASSPORT?

AtMSD,webelievethatpharmaceuticalinnovationistheresultofasophisticatedpolicyframeworkthatsupportsscience,healthcare,andindustrialpolicyfocusedonbuildingaknowledgeeconomy.

EUinstitutionsandnationalgovernmentsplayakeyroleinthecreationandsus-tainabilityofourresearchandinnovationecosystem.Theydosobyinvestinginfun-damentalscience,financinghealthcare,andprovidingincentivestoattractprivatesectorinvestmentinpharmaceuticalinnovation.Thiswebofpublicpoliciesprovidesthecon-ditionsforpharmaceuticalcompaniessuchasMSDtoinvestanddevelopinnovativetreat-mentsthatbenefitpatientsandsocieties.

In2021alone,research-basedpharmaceuti-calcompanieshaveinvestedanestimated€42,5billioninRDinEurope1

AstheEUisembarkingonacomprehen-sivereformofitsgeneralpharmaceuticallegislation,ourPolicyPassportisintendedtoprovidepolicymakersandotherstake-holderswitha“roadmap”ofthedriversandcriticalpoliciesthatsupportpharmaceuticalinnovation.

Iwantt